All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0922-ZP1363 | Anti-DR5 (Tigatuzumab) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | Tigatuzumab | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-1022-ZP181 | Anti-DR5 (LaDR5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | LaDR5 | Mouse | scFv-41BB-CD33ζ | Lentiviral vector | T cell | ||
XS-1022-ZP207 | Anti-DR5 (BDF1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | BDF1 | Human | scFv-41BB-CD38ζ | Lentiviral vector | T cell | ||
XS-0123-ZP743 | Anti-DR5 (Tigatuzumab) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | Tigatuzumab | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP138 | Anti-DR5 (Conatumumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Conatumumab | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP139 | Anti-DR5 (Drozitumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Drozitumab | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP140 | Anti-DR5 (Apomab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Apomab | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP141 | Anti-DR5 (AMG655 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | AMG655 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP484 | Anti-DR5 (MD5-1 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | MD5-1 | Hamster | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP743 | Anti-DR5 (Tigatuzumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Tigatuzumab | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-LX3998 | TRAC-DR5 (X3XT200) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT200 | Human | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3999 | TRAC-DR5 (X3XT201) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT201 | Humanized | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4000 | TRAC-DR5 (X3XT202) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT202 | Human | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4240 | TRAC-DR5 (X3XT200) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT200 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4241 | TRAC-DR5 (X3XT201) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT201 | Humanized | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4242 | TRAC-DR5 (X3XT202) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT202 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4482 | TRAC-DR5 (X3XT200) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT200 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4483 | TRAC-DR5 (X3XT201) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT201 | Humanized | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4484 | TRAC-DR5 (X3XT202) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT202 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0823-LX37 | Anti-hDR5 (MAB) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | MAB | Adenoviral vectors | |||||
XS-0923-LX92 | Anti-hDR5 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-61 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION